Annovis Bio Inc (ANVS)
8.03
-0.69
(-7.91%)
USD |
NYSE |
May 16, 16:00
7.77
-0.26
(-3.24%)
After-Hours: 20:00
Annovis Bio Shareholders Equity (Quarterly): -3.354M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -3.354M |
| December 31, 2023 | -7.751M |
| September 30, 2023 | 6.658M |
| June 30, 2023 | 20.74M |
| March 31, 2023 | 20.14M |
| December 31, 2022 | 28.32M |
| September 30, 2022 | 29.96M |
| June 30, 2022 | 35.23M |
| March 31, 2022 | 42.04M |
| December 31, 2021 | 44.50M |
| September 30, 2021 | 46.53M |
| Date | Value |
|---|---|
| June 30, 2021 | 48.61M |
| March 31, 2021 | 4.368M |
| December 31, 2020 | 7.541M |
| September 30, 2020 | 9.121M |
| June 30, 2020 | 9.498M |
| March 31, 2020 | 10.69M |
| December 31, 2019 | -8.576M |
| September 30, 2019 | -8.375M |
| June 30, 2019 | -8.121M |
| March 31, 2019 | -7.776M |
| December 31, 2018 | -7.594M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-8.576M
Minimum
Dec 2019
48.61M
Maximum
Jun 2021
16.39M
Average
10.10M
Median
Shareholders Equity (Quarterly) Benchmarks
| Ligand Pharmaceuticals Inc | 806.52M |
| ANI Pharmaceuticals Inc | 476.81M |
| FibroGen Inc | -228.12M |
| Cerus Corp | 49.37M |
| Stereotaxis Inc | 20.03M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.813M |
| Total Liabilities (Quarterly) | 11.17M |